Catalyst

$BIIB

- Develops therapies for neurological diseases

BIIB

$216.03

+6.97%

What changed

$BIIB - Develops therapies for neurological diseases - REV +2% to $2.5B - EPS +18% to $3.57

Why it matters

- Develops therapies for neurological diseases

Sources

pipeline